Brain sciences

Chemotherapy-linked Thinking Problems: Immune System, Gut-Brain Communication, and Possible Treatments

Updated

Abstract

Chemotherapy-related cognitive impairment (CRCI) affects between 17% and 70% of cancer patients.

  • CRCI, often termed 'chemobrain,' can last from months to years and significantly impacts social, educational, and occupational functioning.
  • Cognitive deficits associated with CRCI may interfere with medication adherence and health-related behaviors, potentially affecting survival outcomes.
  • Chemotherapy induces a cascade of biological events including systemic inflammation, intestinal dysbiosis, and blood-brain barrier disruption.
  • Neuroinflammation, reduced neurogenesis, and oxidative stress are among the underlying mechanisms contributing to cognitive decline in CRCI.
  • Emerging studies indicate a link between microbiome changes and cognitive decline, highlighting the gut-brain axis's role in CRCI.
  • Several biomarkers and screening tools have been proposed to identify CRCI, but current pharmacological and lifestyle interventions remain largely unvalidated.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free